Mozambique's medicines regulator. It grants marketing authorisation by registration, notification or special and emergency import, and reports reaching WHO maturity level 3, which the Minister of Health highlighted in September 2026.
The Autoridade Nacional Reguladora de Medicamento (ANARME, IP) grants marketing authorisation (Autorização de Introdução no Mercado) after assessing quality, safety and efficacy; its website says authorisation can be by registration, notification or special and emergency import. It also licenses those who make, import, export, distribute and sell medicines, runs pharmacovigilance and clinical trial oversight, and tests product quality. An ANARME news item dated 10 September 2026 reports that at the opening of the 51st Health Coordinating Council in Beira the Minister of Health, Ussene Isse, named its reaching maturity level 3 as one of the sector's greatest achievements of recent years. The item does not name WHO; a headline on ANARME's home page ties the level to meeting WHO's recommendations. ANARME's board chair is Tânia Vuyeya Sitoie. The coordinates on this record are an approximate Maputo point.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/